COVID-19 related myocarditis may exacerbate pre-existing mild mitral valve prolapse, leading to severe symptomatic mitral regurgitation requiring surgical intervention despite medical therapy.
Answers are grounded in this paper and cite their sources.
May suggest COVID-19 myocarditis exacerbates mitral prolapse; hypothesis-generating and should not yet change practice.
The authors reported two patients with a history of asymptomatic mild mitral valve prolapse, a male in his late 40s (Case 1, vaccinated) and a female in her late 20s (Case 2, unvaccinated), who developed worsening (severe) mitral prolapse and New York Heart Association symptoms class III-IV after exposure to coronavirus disease 2019 with evidence of myocarditis on MRI. Both patients received similar 6-month of heart failure therapy; however, the outcomes did not affect the severity of their symptoms or mitral regurgitation. Subsequently, both patients underwent mitral valve surgery.
No takes yet. Share an insight, caveat, or question.
Shonafi et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: